ST2 in patients with severe aortic stenosis and heart failure
BACKGROUND: ST2 is a circulating biomarker that is well established for predicting outcome in heart failure (HF). This is the first study to look at ST2 concentrations in optimally treated patients with stable but significant left ventricular systolic dysfunction (LVSD) compared to patients with sev...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Via Medica
2021-02-01
|
| Edice: | Cardiology Journal |
| Témata: | |
| On-line přístup: | https://journals.viamedica.pl/cardiology_journal/article/view/62738 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
